ReviewCancers2023

Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer.

Marco Siringo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.